Differentiation of MEFs - Revision history

Nporitsa at 20:02, 23 December 2013

2013-12-23T20:02:34Z

← Older revision		Revision as of 20:02, 23 December 2013
Line 1:		Line 1:

	==Protocol== Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)		==Protocol==
	==Strains== Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs		Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
	==Source== DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)		==Strains==
			Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
			==Source==
			DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
	==Papers==		==Papers==
	• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.		• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.

Nporitsa at 20:02, 23 December 2013

2013-12-23T20:02:21Z

← Older revision		Revision as of 20:02, 23 December 2013
Line 1:		Line 1:

	==Protocol==Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)		==Protocol== Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
	==Strains==Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs		==Strains== Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
	==Source==DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)		==Source== DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
	==Papers==		==Papers==
	• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.		• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.

Nporitsa at 20:02, 23 December 2013

2013-12-23T20:02:05Z

← Older revision		Revision as of 20:02, 23 December 2013
Line 1:		Line 1:

	~~'''~~==Protocol==~~'''~~Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)		==Protocol==Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
	~~'''~~==Strains==~~'''~~ Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs		==Strains==Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
	~~'''~~==Source==~~'''~~ DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)		==Source==DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
	==Papers==		==Papers==
	• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.		• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.

Nporitsa at 20:01, 23 December 2013

2013-12-23T20:01:42Z

← Older revision		Revision as of 20:01, 23 December 2013
Line 3:		Line 3:
	'''==Strains==''' Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs		'''==Strains==''' Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
	'''==Source==''' DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)		'''==Source==''' DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
	~~'''~~==Papers==~~'''~~		==Papers==
	• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.		• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.
	• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.		• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.

Nporitsa at 20:01, 23 December 2013

2013-12-23T20:01:18Z

← Older revision		Revision as of 20:01, 23 December 2013
Line 1:		Line 1:

	Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)		'''==Protocol=='''Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
	Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs		'''==Strains==''' Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
	Source: DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)		'''==Source==''' DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
	Papers:		'''==Papers=='''
	• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.		• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.
	• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.		• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.

	Materials		==Materials==
	• DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)		• DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)
	• FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)		• FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)

Nporitsa: /* Induction of MEF differentiation */

2013-12-23T19:58:50Z

Induction of MEF differentiation

← Older revision		Revision as of 19:58, 23 December 2013
Line 24:		Line 24:
	# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).		# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).
	# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).		# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).
	3. At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).		# At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off). '''Note1:''' Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)
	• Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)		# Protein lysate and RNA extraction is taken at day 4 (D3). '''Note2:''' In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection. '''Note3:''' A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.
	4. Protein lysate and RNA extraction is taken at day 4 (D3).
	• Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.
	• Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.

Nporitsa: Created new page

2013-12-23T19:54:18Z

Created new page

New page

Protocol: Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs)
Strains: Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs
Source: DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA)
Papers:
• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534.
• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, et al. (2003) Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223–1233.

Materials
• DMEM (4.5 g/L glucose + L-glutamine – sodium pyruvate; Invitrogen catalog # 11965-092)
• FBS (we test several batches from several sources for differentiation and insulin stimulated glucose uptake then order large quantities of that particular lot. Currently we are using Sigma cat# F2442, lot# 072K8403. Aliquot and store in 50 mL tubes at -20)
• NCS (currently we are using Biowhittaker Cambrex cat# 14-416F, lot# 01106776; aliquot in 50 mL tubes and store at -20)
• Penicillin/Streptomycin (100X Invitrogen Cat# 100378-016)
• Insulin (Sigma I-5523). Dissolve in 0.01N Hydrochloric acid (28.7μl/50ml) as a 1 mg/ml stock. Aliquot into 1.5 mL tubes and store at -20
• Dexamethasone (Sigma D-1756). Dissolve in ethanol as a 2.5 mM stock (0.049g/50ml). Aliquot into 1.5 tubes and store at -20.
• MIX (Sigma I-5879). Add 2.78g MIX and 0.98g KOH and bring up to 50 mL. Aliquot into 1.5 mL tubes and store at -20
• Fibroblast Media (DMEM + 10% NCS + 1X PSG; Sterile filter into new bottle)
• Adipocyte Media (DMEM + 10 % L1-FBS + 1X PSG; Sterile filter into new bottle)
• DMI Media (Adipocyte Media + Insulin (1000X dilution), Dexamethasone (10 000X dilution) and MIX (500X dilution); Sterile filter into new bottle after additions
• Insulin Media (Adipocyte Media + Insulin; Sterile filter into new bottle after adding insulin)

==Induction of MEF differentiation==
# Seed MEFs at 100% confluence in 12-well plates and grow for 2 days (D0).
# On day 0 (D0) treat MEFs with differentiation-inducing media containing insulin (830 nM), dexamethasone (1 µM), and 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM).
3. At 48 hours, replace the media with the maintenance DMEM medium containing 10% FBS and insulin (830-nM), followed by a replenishment of the media every 2 days until the end of adipogenic differentiation (prior to cells lifting off).
• Note1 Cells should shrink after day 1, and then start to round up. By *day 3 cells should begin to accumulate lipid (the media should change color as well)
4. Protein lysate and RNA extraction is taken at day 4 (D3).
• Note2: In the 12-well plate, Tsc2-/- MEFs started to be detached from the plate on D3, and consequently lysates were taken at that point to ensure adequate sample collection.
• Note3: A 6-well plate can also be used to increase surface area and protein/RNA content from each treatment. Seeding density of 90% followed by 2 days of growth prior to adipogenic differentiation may increase adherence and maintenance of Tsc2-/- MEFs.